Please ensure Javascript is enabled for purposes of website accessibility

3 Top Robinhood Stocks Wall Street Thinks Will Soar 25% or More

By Keith Speights - Updated Jun 4, 2021 at 8:24AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Analysts expect one of them to skyrocket a lot more than 25%.

Robinhood investors like quite a few stocks that aren't exactly favorites for analysts. If memes are floating on the internet about a given stock, there's a pretty good chance that it's popular on Robinhood but not so much on Wall Street.

However, there are also several stocks that retail investors on the commission-free trading platform and analysts alike hold in high regard. Here are three top Robinhood stocks that Wall Street thinks will soar 25% or more. 

Person wearing glasses in front of a PC screen with a large stock chart displayed in the background.

Image source: Getty Images.


You might think that with a market cap topping $2 trillion, there's not much room for Apple (AAPL 2.14%) to grow. Analysts would disagree. The average one-year price target for the technology leader reflects a premium of nearly 28% over the current share price.

Apple is the second-most widely held stock among Robinhood investors. Why? Probably because they realize the incredible moat and growth prospects that Apple enjoys with its iPhone-centric ecosystem.

I think this ecosystem could expand enough for Apple to hit Wall Street's price target. The increased availability of high-speed 5G wireless networks continues to fuel demand for the newer iPhone models. Apple's services and wearables revenue also continues to grow significantly.

Over the long run, my view is that technological innovations will keep Apple among the favorite stocks for both Robinhood investors and Wall Street analysts. Look for more augmented reality functionality on the way. There's also speculation that Apple could launch a foldable iPhone in 2023. A future market cap of $3 trillion or more isn't out of the question at all.

Robinhood investors and analysts also agree on another so-called FAANG stock -- (AMZN 2.07%). The internet giant ranks as the ninth most popular stock on Robinhood. Analysts think that Amazon's share price could rise 31% over the next 12 months. 

There are two key growth drivers that could enable Amazon to deliver that kind of growth. The company's Amazon Web Services (AWS) cloud platform continues to fire on all cylinders and is highly profitable. Amazon is also experiencing strong momentum with its digital advertising business.

Value investor Bill Miller even thinks that these two units could account for most of Amazon's valuation within the next couple of years. He's also bullish about the company's business-to-business and logistics platforms. I suspect Miller's optimism is on point.

Don't forget e-commerce, though. Amazon remains the biggest e-commerce company in the world. Online sales still account for less than 14% of total retail sales in the U.S. There's a lot of room for Amazon to run in its core business.

Bionano Genomics

You might be at least a little surprised by the third top Robinhood stock on our list that Wall Street really likes. The average price target for Bionano Genomics (BNGO 6.51%) is a whopping 80% higher than the stock's current price.

Bionano reported better-than-expected Q1 results in May. Revenue jumped 179% year over year to a record-high $3.2 million. Although the company remained unprofitable, its bottom line moved in the right direction.

Customers appear to like Bionano's Saphyr genome mapping system. As the install base grows, the company's recurring revenue from consumables grows. That's the kind of business model that investors hope could really pay off over the long run.

Bionano projects that it will have 150 Saphyr systems in the field by the end of this year, up 50% from the end of 2020. The company also anticipates receiving accreditation for additional laboratory-developed tests for Saphyr soon. Bionano is riskier than Apple or Amazon, but analysts think it could be a huge winner over the near term.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Keith Speights owns shares of Amazon and Apple. The Motley Fool owns shares of and recommends Amazon and Apple. The Motley Fool recommends the following options: long January 2022 $1,920 calls on Amazon, long March 2023 $120 calls on Apple, short January 2022 $1,940 calls on Amazon, and short March 2023 $130 calls on Apple. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Bionano Genomics, Inc. Stock Quote
Bionano Genomics, Inc.
$3.60 (6.51%) $0.22
Apple Inc. Stock Quote
Apple Inc.
$172.10 (2.14%) $3.61, Inc. Stock Quote, Inc.
$143.55 (2.07%) $2.91

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/14/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.